Brain Modulation in patients with Autoimmune Diseases

Not Applicable

Recruiting

• Conditions: Fatigue Syndrome, Chronic; Chronic pain; Lupus Erythematosus, Systemic; C20.111

• Registration Number: RBR-6c6f8yv
• Lead Sponsor: Faculdade de Medicina da Universidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-02-28
• Last Update Posted: 29 May 2023
• Study Completion: 2025-09-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Female patients with the defined systemic autoimmune disease Systemic Lupus Erythematosus (all meet the 2019 EULAR/ACR classification criteria); in regular outpatient follow-up; having a picture of fatigue or significant pain; presenting the Severity of Fatigue Scale (EGF) greater than or equal to 36 points; relatively stable use of medication in the last month; able to understand and complete the Free and Informed Consent Form (TCLE)

Exclusion Criteria

Patients with: neoplasms; cardiac pacemaker users; users of cranial metal clips or prostheses; pregnant women; personal history of seizures or epilepsy; users of centrally-acting drugs or drugs that lower the seizure threshold; skin lesion on the scalp; in moderate, intense or very intense disease activity; using moderate to high doses of glucocorticoids; overlapping with systemic autoimmune rheumatic diseases other than antiphospholipid antibody syndrome

Study & Design

• Study Type: Intervention
• Study Design: Not specified